Arjun Sood, MD
Ophthalmology · Blue Ash, OHNPI 1487097341
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,865 of the $98,524 with a category attached, or 67.9%. 28 manufacturers reported payments, led by Eyepoint US, Inc. at 29.2% of the total. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $419.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$29K
- Alimera Sciences, Inc.$29K
- ANI Pharmaceuticals, Inc.$18K
- Carl Zeiss Meditec, Inc.$7K
- Neurotech Pharmaceuticals, Inc.$6K
- Genentech USA, Inc.$4K
- plus $7K from 22 others
What the payments were for
- Consulting fees$19,54920%
- Speaking & faculty fees$66,86568%
- Travel & lodging$4,0904%
- Food & beverage$7,9058%
- Education$980%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 41 | $28,738 |
| Alimera Sciences, Inc. | 33 | $28,730 |
| ANI Pharmaceuticals, Inc. | 15 | $17,534 |
| Carl Zeiss Meditec, Inc. | 9 | $6,785 |
| Neurotech Pharmaceuticals, Inc. | 2 | $6,159 |
| Genentech USA, Inc. | 17 | $3,997 |
| Regeneron | 7 | $1,699 |
| AbbVie(2 entities) | 36 | $1,112 |
| Dutch Ophthalmic, USA | 1 | $840 |
| Carl Zeiss Meditec USA, Inc. | 4 | $563 |
| Regeneron Healthcare Solutions, Inc. | 18 | $547 |
| Astellas Pharma US Inc | 9 | $396 |
| Alcon | 3 | $375 |
| Bausch & Lomb Americas Inc. | 9 | $227 |
| Apellis Pharmaceuticals, Inc. | 6 | $134 |
| Ocular Therapeutix, Inc. | 3 | $123 |
| Mallinckrodt Hospital Products Inc. | 2 | $120 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $81 |
| Sandoz | 3 | $66 |
| Harrow Eye, LLC | 2 | $64 |
| Biogen | 2 | $41 |
| Merck | 2 | $38 |
| Samsara Vision | 1 | $31 |
| Biotissue Holdings Inc. | 1 | $31 |
| Novartis | 2 | $29 |
| Amgen | 1 | $28 |
| Coherus Oncology, Inc. | 1 | $20 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YUTIQ$49,777
- Iluvien$27,868
- PURIFIED CORTROPHIN GEL$17,119
- Lucentis$3,300
- ENCELTO$3,060
- ARTEVO 800$3,023
- Cataract Suite$1,238
- CIRRUS HD-OCT$1,238
- IOLMaster 700$1,238
- VisuMax$1,238
- EVA, combined machine$840
- TISSUEBLUE$840
- CIRRUS 6000 with AngioPlex$813
- CLARUS$813
- FORUM Glaucoma Workplace$813
- Humphrey Field Analyzer (HFA3)$813
- Retina Workplace$813
- SUSVIMO$298
- OZURDEX$262
- LUMERA 700$223
How this compares
$98,524 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 241 | $7,953 |
| Difluprednate | 33 | $3,433 |
| Ketorolac Tromethamine | 30 | $1,319 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 67 | $1,120 |
| Tobramycin | 100 | $517 |
| Brimonidine Tartrate | 64 | $407 |
| Dorzolamide Hcl | 11 | $242 |
| Latanoprost | 19 | $196 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Blue Ash
- Lucas LindsellBlue Ash$142K
- Alison EarlyBlue Ash$69K
- James OsherBlue Ash$11K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.